The development frequency of duodenal and gastric ulcer recurrence associated with Helicobacter pylori after eradication therapy

被引：0
|
作者：
Kazakbaeva, J
Meka-Mechenko, TV
Zhangabylov, A
Esnazarova, G
机构：
[1] Kazakh Sci Ctr Quarantine & Zoonot Dis, Alma Ata, Kazakhstan
[2] Kazakh Med Inst, Alma Ata, Kazakhstan
来源：
HELICOBACTER | 2005年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：539 / 539
页数：1
相关论文
共 50 条
  • [41] Fromilid (clarithromycin) in eradication therapy of duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variants)
    Vasilyev, YV
    Zvenigorodskaya, LA
    Kolomiets, EV
    Firsanova, VY
    TERAPEVTICHESKII ARKHIV, 2002, 74 (08) : 58 - 60
  • [42] Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases
    Take, Susumu
    Mizuno, Motowo
    Ishiki, Kuniharu
    Nagahara, Yasuhiro
    Yoshida, Tomowo
    Yokota, Kenji
    Oguma, Keiji
    JOURNAL OF GASTROENTEROLOGY, 2007, 42 (Suppl 17) : 21 - 27
  • [43] Helicobacter pylori infection and gastric microbiota: Insights into gastric and duodenal ulcer development
    Pan, Yan
    Jiao, Fu-Yong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (07)
  • [44] Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases
    Susumu Take
    Motowo Mizuno
    Kuniharu Ishiki
    Yasuhiro Nagahara
    Tomowo Yoshida
    Kenji Yokota
    Keiji Oguma
    Journal of Gastroenterology, 2007, 42 : 21 - 27
  • [45] MUC 1 mucin content in gastric juice of duodenal ulcer patients: effect of Helicobacter pylori eradication therapy
    I. Radziejewska
    D. G. Kisiel
    M. Borzym-Kluczyk
    A. Kluz
    Z. Namiot
    A. Gindzieński
    Clinical and Experimental Medicine, 2007, 7 : 72 - 76
  • [46] MUC 1 mucin content in gastric juice of duodenal ulcer patients:: Effect of Helicobacter pylori eradication therapy
    Radziejewska, I.
    Kisiel, D. G.
    Borzym-Kluczyk, M.
    Kluz, A.
    Namiot, Z.
    Gindzienski, A.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2007, 7 (02) : 72 - 76
  • [47] Eradication of Helicobacter pylori for the prevention of ulcer bleeding recurrence
    Gisbert, J. P.
    Garcia-Gravalos, R.
    Calvet, X.
    Feu, F.
    Pique, J. M.
    Cosme, A.
    Bory, F.
    Canete, N.
    Santolaria, S.
    Montoro, M.
    Benages, A.
    Almela, P.
    Borda, F.
    Arnaez, R.
    Castro, M.
    Perez-Aisa, A.
    Fernandez, N.
    Olivares, D.
    HELICOBACTER, 2006, 11 (04) : 395 - 396
  • [48] Eradication of Helicobacter pylori for the prevention of ulcer bleeding recurrence
    Gisbert, JP
    Garcia-Gravalos, R
    Feu, F
    Pique, M
    Bory, F
    Cañete, N
    Benages, A
    Almela, P
    Borda, F
    Aznarez, R
    Calvet, X
    Santolaria, S
    Montoro, M
    Cosme, A
    Perez-Aisa, A
    Fernandez, N
    Castro-Fernandez, M
    Olivares, D
    Pajares, JM
    HELICOBACTER, 2005, 10 (05) : 532 - 532
  • [49] Eradication of Helicobacter pylori for the prevention of ulcer bleeding recurrence
    Gisbert, Javier P.
    Garcia-Gravalos, R.
    Olivares, D.
    Calvet, X.
    Feu, F.
    Pique, Jm
    Cosme, A.
    Bory, F.
    Canete, N.
    Santolaria, S.
    Montoro, M.
    Benages, A.
    Almela, P.
    Borda, F.
    Aznarez, R.
    Castro, M.
    Perez-Aisa, A.
    Fernandez, N.
    GASTROENTEROLOGY, 2006, 130 (04) : A465 - A465
  • [50] History of Helicobacter pylori,duodenal ulcer,gastric ulcer and gastric cancer
    David Y Graham
    World Journal of Gastroenterology, 2014, (18) : 5191 - 5204
12345